Related Experiment Video
Updated: May 29, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
A breakdown of the Hippo pathway in gastric cancer
Zhi Peng Xu1, Jin Shui Zhu, Qiang Zhang
1Department of Gastoenterology, Jiao Tong University, Shanghai, China.
Background/Aims:
The Hippo pathway is a newly discovered signaling pathway. In mammals, the Hippo pathway was reported to be a tumor-suppressor signaling that inhibited cell proliferation and promoted cell apoptosis. Inactivation of the Hippo pathway resulted in massive cell growth, enlargement in organ size and eventually cancer formation. The aim of this study was to investigate the expression of core component proteins of the Hippo pathway, Mst1/2,S Sav1 and Lats1, in normal gastric mucosa, intestinal metaplasia and gastric cancer, and to explore the role of the Hippo pathway in gastric cancer.
Methodology:
Two-step immunohistochemical staining was used to detect the expression of Mst1/2, Sav1 and Lats1 in 46 cases of normal gastric mucosa, 37 cases of intestinal metaplasia and 78 cases of gastric cancer.
Results:
The expression of Mst1/2 and Lats1 was down-regulated in gastric cancer compared with that in normal gastric epithelium and adenoma. The Sav1 expression showed an increased trend from normal mucosa through intestinal metaplasia to gastric cancer, though there was no statistically significant difference. The expression of Sav1 and Lats1 in gastric cancer with lymph node metastasis was significantly lower than that without lymph node metastasis.
Conclusions:
A breakdown of the Hippo pathway may play a role in tumorigenesis and metastasis of gastric cancer.
Insights
The Hippo pathway
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Hippo pathway is a critical tumor suppressor pathway.
- Its inactivation leads to uncontrolled cell growth and cancer.
- Understanding its role in gastric cancer is crucial.
Purpose of the Study:
- Investigate Hippo pathway core protein expression (Mst1/2, Sav1, Lats1).
- Analyze expression in normal gastric mucosa, intestinal metaplasia, and gastric cancer.
- Explore the Hippo pathway's role in gastric cancer development and progression.
Main Methods:
- Immunohistochemical staining.
- Analysis of Mst1/2, Sav1, and Lats1 expression in 161 gastric tissue samples (46 normal, 37 metaplasia, 78 cancer).
Main Results:
- Mst1/2 and Lats1 expression were significantly down-regulated in gastric cancer.
- Sav1 expression showed an increasing trend from normal to cancer, but not statistically significant.
- Lower Sav1 and Lats1 expression correlated with lymph node metastasis in gastric cancer.
Conclusions:
- Hippo pathway dysregulation is implicated in gastric cancer tumorigenesis.
- The pathway's breakdown may contribute to gastric cancer metastasis.
Related Concept Videos
Gastritis II: Pathophysiology
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

